Results 131 to 140 of about 292,778 (314)
Immunosuppressive substance in the sera of head and neck cancer patients [PDF]
Noboru Yamanaka +3 more
openalex +1 more source
Highlights in head and neck cancer [PDF]
Abstract: During the 2020 annual ASCO meeting, the most recent advances in squamous cell carcinoma of the head and neck as well as nasopharyngeal carcinoma were discussed. First of all, weekly cisplatin proved to be non-inferior to three-weekly cisplatin in the postoperative setting. Next, several interesting studies in both locoregionally advanced and
openaire +7 more sources
The developed graphene‐assisted plasmonic nanocoral platform enables sensitive, label‐free surface‐enhanced Raman scattering analysis of salivary metabolites for head and neck cancer (HNC) detection. When combined with machine learning classification and nonnegative least squares‐based spectral deconvolution, this approach achieves 98% diagnostic ...
Hyo Jeong Seo +11 more
wiley +1 more source
Dose perturbation resulting from gold fillings in patients with head and neck cancers
Valsa Thambi +3 more
openalex +1 more source
Induction therapy in head and neck cancer. A comparison of two regimens [PDF]
Monica B. Spaulding +6 more
openalex +1 more source
In this study, we investigated the impact of circular stapler size on both short‐term outcomes and long‐term QOL after McKeown esophagectomy. We revealed that short‐term outcomes, including anastomotic leakage and stenosis, did not differ between patients who underwent anastomosis with a 21 mm stapler and those with a 23 mm stapler.
Suguru Maruyama +9 more
wiley +1 more source
Regional chemotherapy through a saphenous vein graft for the treatment of head and neck cancers [PDF]
T. K. Choi, WI Wei, W. F. Lau, K. H. Lam
openalex +1 more source
Nanozymes for Non‐Neoplastic Diseases: Catalytic Therapy Redefined
Non‐neoplastic diseases pose a significant health burden. Nanozymes, enzyme‐like nanomaterials, offer promising strategies for regulating oxidative stress and inflammation. This review explores their development, structure–function relationships, and therapeutic potential, with a focus on precision medicine through targeted delivery and multimodal ...
Ling Mei +8 more
wiley +1 more source
Distribution of survival times of 12,000 head and neck cancer patients who died with their disease
Richard F. Mould +3 more
openalex +2 more sources
A randomized prospective comparison of intermittent methotrexate, methotrexate with leucovorin, and a methotrexate combination in head and neck cancer [PDF]
Ronald C. DeConti, David Schoenfeld
openalex +1 more source

